IDR Data
CMS PUF data · 2023 Q1–2025 Q4

Federal IDR outcomes: Neurosurgery and spine surgery in Wisconsin

In 2025 Q1–Q4, the provider or facility offer prevailed in 94.4% of 2,449 determined Federal IDR dispute line items for neurosurgery and spine surgery in Wisconsin. The median prevailing offer was 23.84x the QPA (25th–75th percentile 12.32x–41.59x; n = 2,225). The median time to a decision was 43 business days (n = 2,449).

Determined line items

2,449

2025 Q1–Q4 · 5 split decisions excluded

Provider win rate

94.4%

n = 2,449 · 2025 Q1–Q4

Median payment vs QPA

23.84x †

middle half 12.32x–41.59x · n = 2,225 · 2025 Q1–Q4

Median days to decision

43

business days, from dispute initiation · n = 2,449 · 2025 Q1–Q4

Dollar amounts are not shown for specialty groups: the CMS QPA and Offers file, the only source of dollar figures, has no specialty field. See methodology.

By period

PeriodLine itemsWin %Median ×QPA25th–75thRatio nMedian days
2025 Q1–Q42,44994.4%23.84x †12.32x–41.59x2,22543
2024 Q1–Q41,20987.7%23.62x †10.00x–51.71x1,13950
2023 Q1–Q4Fewer than 30 determined line items; not shown.
2023 Q1–2025 Q43,66592.2%23.78x †11.52x–43.97x3,371not pooled

Line items = determined dispute line items (n). Win rate excludes split decisions and includes default decisions. Ratio n = line items reporting a payment-to-QPA ratio. Days are business days as reported by CMS (2023–2024: from IDR entity assignment; 2025: from initiation) and are never pooled.

Most disputed CPT codes

CPT codeLine itemsWin %Median ×QPARatio nMedian days
64483 Injection of anesthetic and/or steroid drug into sacral spine nerve root using i17195.3%20.21x †16043
62321 Injection of substance into middle or upper spine canal using imaging guidance12993.8%20.38x †12338
64772 Incision or removal of spinal nerve12993.0%50.84x †11157
64484 Injection of anesthetic and/or steroid drug into sacral spine nerve root using i11298.2%24.08x †10240
64493 Injection of lower or sacral spine facet joint using imaging guidance, single le10291.2%17.56x9643
99152 Use of a drug to induce depression of consciousness by physician performing a pr10298.0%22.42x †9043
64490 Injection of upper or middle spine facet joint using imaging guidance, single le9196.7%20.04x †9049
64494 Injection of lower or sacral spine facet joint using imaging guidance, second le8188.9%23.62x †6336
72141 MRI scan of upper spinal canal without contrast6995.7%21.70x †6348
64491 Injection of upper or middle spine facet joint using imaging guidance, second le6695.5%28.03x †6347.5
36224 Insertion of tube into internal neck artery for diagnosis or treatment with revi6296.8%42.44x †5687.5
36226 Insertion of tube into brain artery for diagnosis or treatment with review by ra6195.1%54.87x †5547
72148 MRI scan of lower spinal canal without contrast6198.4%24.06x †5735
22853 Insertion of cage or mesh device to spine bone and disc space during spine fusio5893.1%72.34x †5346.5
36227 Insertion of tube into external neck artery for diagnosis or treatment with revi4998.0%70.10x †4272
27096 Injection of anesthetic or steroid into joint between lower spine and hip bone u4895.8%17.43x4839.5
72158 MRI scan of lower spinal canal before and after contrast3997.4%20.91x †3745
72131 CT scan of lower spine without contrast3892.1%30.49x †3735
22551 Fusion of upper spine bone with removal of disc and release of spinal cord or ne3786.5%16.50x3540
22842 Placement of stabilizing device to back, 3-6 spine bone segments3588.6%26.97x †3358

2025 Q1–Q4 · rows with n ≥ 30 determined line items · sorted by n.

Related: all specialties in Wisconsin · Neurosurgery and spine surgery in all states

FAQ

What is the Federal IDR provider win rate for neurosurgery and spine surgery in Wisconsin?

In 2025 Q1–Q4, the provider or facility offer was selected in 94.4% of 2,449 determined dispute line items for neurosurgery and spine surgery in Wisconsin. Split decisions are excluded from the denominator and default decisions are included. Withdrawn, settled and ineligible disputes are not in the CMS data.

How do Federal IDR payments compare with the QPA for neurosurgery and spine surgery in Wisconsin?

In 2025 Q1–Q4, the median prevailing offer was 23.84x the qualifying payment amount (QPA), with a 25th to 75th percentile range of 12.32x to 41.59x (n = 2,225 line items). This uses the CMS field Prevailing Party Offer as % of QPA, where 1.00x equals the QPA.

How long do Federal IDR decisions take for neurosurgery and spine surgery in Wisconsin?

In 2025 Q1–Q4, the median was 43 business days (n = 2,449 line items), using the CMS field Length of Time to Make Determination (from dispute initiation).

How to Utilize IDR